KRAS mutations activate ARL4C, which recruits MMP14 via its interaction with IQGAP1, forming invasive pseudopodia that contribute to the uncontrolled invasion and metastasis of pancreatic cancer (58). Here, IQGAP1 is linked to familial pancreatic carcinoma.